Labcorp (LH) Form 144: planned sale of 5,745 shares, $1.51M

Laboratory Corporation of America Holdings (LH) reported a Form 144 notice of a proposed sale of 5,745 common shares, with an aggregate market value of $1,509,498.75.

Rhea-AI Filing Summary

Laboratory Corporation of America Holdings (LH) reported a Form 144 notice of a proposed sale of 5,745 common shares, with an aggregate market value of $1,509,498.75. The filing lists Fidelity Brokerage Services LLC as broker, an approximate sale date of 11/11/2025, and the NYSE as the exchange. Shares outstanding were 82,900,000.

The shares to be sold were acquired through restricted stock vesting on 02/02/2024 (1,911 shares), 02/07/2024 (2,101 shares), and 02/11/2024 (1,733 shares). The filing also shows a recent transaction by a named seller: Adam H. Schechter sold 5,643 shares on 08/11/2025 for $1,505,439.54 in gross proceeds.

Insights

Insider transactions & compliance analyst

Routine Form 144 notice for a modest insider share sale.

This Form 144 lists a proposed sale of 5,745 LH common shares with an aggregate market value of $1,509,498.75, routed through Fidelity and intended for the NYSE. The shares earmarked for sale were acquired via restricted stock vesting on three February 2024 dates, indicating equity compensation being monetized.

Form 144 is a notice requirement for affiliates under Rule 144 and does not itself execute the sale. The excerpt also notes a prior sale on 08/11/2025 of 5,643 shares for $1,505,439.54. Actual trading activity will depend on market conditions and affiliate constraints under Rule 144.

This appears administrative and typical for equity compensation. No use-of-proceeds or company cash flow is involved; transactions occur for the selling holder’s account.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LH shares are covered by this Form 144 notice?

The notice covers a proposed sale of 5,745 common shares.

What is the aggregate market value of the proposed LH share sale?

The aggregate market value listed is $1,509,498.75.

When is the approximate sale date for the LH shares?

The approximate sale date is 11/11/2025.

Which broker and exchange are listed for the LH share sale?

Broker: Fidelity Brokerage Services LLC; Exchange: NYSE.

How were the LH shares to be sold originally acquired?

Through restricted stock vesting on 02/02/2024, 02/07/2024, and 02/11/2024.

How many LH shares were sold in the past three months and for how much?

5,643 shares were sold on 08/11/2025 for $1,505,439.54 in gross proceeds.

What are LH shares outstanding as listed in the notice?

Shares outstanding were 82,900,000.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 11/12/2025 - 06:54 AM EST Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001376841
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	LABCORP HOLDINGS INC.
SEC File Number	001-11353
Address of Issuer	358 S MAIN ST BURLINGTON NORTH CAROLINA 27215
Phone	3362291127
Name of Person for Whose Account the Securities are To Be Sold	Schechter Adam H
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	5745	1509498.75	82900000	11/11/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/02/2024	Restricted Stock Vesting	Issuer			1911	02/02/2024	Compensation
Common	02/07/2024	Restricted Stock Vesting	Issuer			2101	02/07/2024	Compensation
Common	02/11/2024	Restricted Stock Vesting	Issuer			1733	02/11/2024	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Adam H. Schechter 358 South Main Street Burlington NC 27215	Common	08/11/2025	5643	1505439.54

144: Remarks and Signature

Remarks
Date of Notice	11/12/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jennifer Ruchti, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Adam H. Schechter
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)